Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Cancer. 2017 Mar 13;123(13):2535–2542. doi: 10.1002/cncr.30637

Figure 2.

Figure 2

Body Mass Index at Diagnosis and Breast Cancer-Specific Survival among Luminal and Non-Luminal Breast Cancers (n=1,559)

Hazard ratios and confidence intervals are weighted to account for stratified case-cohort study design with strata defined as IHC clinical subtype and adjusted for age, menopausal status, race/ethnicity, study, stage and chemotherapy.